International Association for Premenstrual Disorders

Drawing on clinical and research expertise, Dr. Nayman will unpack how hormonal fluctuations impact emotional coping, and whether traditional psychotherapy models are enough. This session will examine the potential need for cycle-sensitive approaches to better support those living with premenstrual dysphoric disorder (PMDD).

This webinar will arm clinicians with the most up-to-date information to inform the timely and appropriate diagnosis and treatment of premenstrual disorders.

This webinar talks about workplace protections for premenstrual dysphoric disorder (PMDD) and premenstrual exacerbation (PME).

This webinar is a special replay of a recorded professional webinar featuring Dr. Jaclyn Ross, who explores the literature on suicidality in premenstrual disorders.

A webinar with IAPMD to discover how brain science could change PMDD outcomes + Q&A with Emilė Radytė, CEO & Founder of Samphire Neuroscience.

This event supports IAPMD’s mission to equip clinicians with up-to-date tools for timely and accurate diagnosis and treatment, especially focusing on how premenstrual disorders evolve during the menopause transition.

Led by Dr. Jennifer Gordon, the Chair of the Clinical Advisory Board for IAPMD, this engaging session will highlight the most significant advancements in premenstrual disorder research from the past year and what they mean for patients, providers, and the future of care.

Through a powerful real-world case study and a trauma-informed, biopsychosocial lens, Dimple Khatiri unpacks the nuanced diagnostic challenges, unpredictable symptom patterns, and critical need for personalized, multidisciplinary care that truly meets patients where they are.

In this webinar, Dr. Jessica Peters discusses the role of cyclical irritability, anger, and rage in premenstrual disorders and their impact on mental health and relationships. The session explores biological and psychological mechanisms that may contribute to these symptoms, including hormone sensitivity, rejection sensitivity, and secondary emotional responses. Participants will also learn practical strategies to help patients anticipate, understand, and manage these experiences through cycle-informed assessment and evidence-based coping approaches.

The objective of this webinar is to explore the application of a Dialectical Behaviour Therapy (DBT)-informed treatment model for PMDD, as described in a recent peer-reviewed paper (Oliveri et al., 2025).

This webinar explores the connection between hormonal changes and binge eating across the menstrual cycle, highlighting how fluctuations in estrogen and progesterone can influence risk.

People with PMDD experience significantly higher rates of suicidal thoughts and behaviors, yet the pathways driving this risk remain poorly understood. This webinar introduces a PMDD-adapted version of the Integrated Motivational-Volitional (IMV) model of suicide, highlighting how cyclical symptoms may contribute to the development of suicidal ideation and behavior and discussing implications for prevention and clinical care.